Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.
Date Value
November 13, 2026 3.456M
November 12, 2026 4.762M
November 11, 2026 2.213M
November 10, 2026 2.213M
November 09, 2026 2.107M
November 06, 2026 2.224M
November 05, 2026 2.224M
November 04, 2026 2.376M
November 03, 2026 2.336M
November 02, 2026 2.320M
October 30, 2026 2.426M
October 29, 2026 2.256M
October 28, 2026 2.288M
October 27, 2026 2.320M
October 26, 2026 2.224M
October 23, 2026 2.298M
October 22, 2026 2.216M
October 21, 2026 2.320M
October 20, 2026 2.383M
October 19, 2026 2.213M
October 16, 2026 2.075M
October 15, 2026 2.351M
October 14, 2026 1.959M
October 13, 2026 2.341M
October 12, 2026 2.373M
Date Value
October 09, 2026 2.562M
October 08, 2026 2.521M
October 07, 2026 2.468M
October 06, 2026 2.521M
October 05, 2026 2.436M
October 02, 2026 2.404M
October 01, 2026 2.309M
September 30, 2026 2.075M
September 29, 2026 2.277M
September 28, 2026 2.128M
September 25, 2026 3.020M
September 24, 2026 2.819M
September 23, 2026 2.808M
September 22, 2026 2.861M
September 21, 2026 2.893M
September 18, 2026 2.755M
September 17, 2026 2.712M
September 16, 2026 2.712M
September 15, 2026 2.606M
September 14, 2026 2.840M
September 11, 2026 2.850M
September 10, 2026 2.744M
September 09, 2026 2.978M
September 08, 2026 3.074M
September 04, 2026 3.020M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Novartis AG 342.80B
Roche Holding AG --
Oculis Holding AG 224.54M
Sandoz Group AG --
Galderma Group AG --